Rowan and eRowan are not being offered in the United States or to U.S. persons. Sifchain’s DEX is not available to people in restricted jurisdictions.
NOTHING IN THIS POST SHALL CONSTITUTE OR BE CONSTRUED AS AN OFFERING OF SECURITIES OR AS INVESTMENT ADVICE, STRATEGY OR INVESTMENT RECOMMENDATIONS BY SIFCHAIN OR ANY OF ITS AFFILIATES.
This communication contains forward-looking statements that are based on our beliefs and assumptions and on information currently available to us. In some cases, you can identify forward-looking statements by the following words: “will,” “expect,” “would,” “intend,” “believe,” or other comparable terminology. These statements involve risks, uncertainties, assumptions, and other factors that may cause actual results or performance to be materially different. We cannot assure you that the forward-looking statements will prove to be accurate. These forward-looking statements speak only as of the date hereof. We disclaim any obligation to update these forward-looking statements.